BeOne Medicines AG (ONC)
NASDAQ: ONC · Real-Time Price · USD
346.50
-7.33 (-2.07%)
At close: Sep 15, 2026, 4:00 PM EDT
340.95
-5.55 (-1.60%)
Pre-market: Sep 16, 2026, 4:06 AM EDT
BeOne Medicines AG Market Cap
BeOne Medicines AG has a market cap or net worth of $39.4 billion as of September 15, 2026. Its market cap has increased by 10.43% in one year.
Market Cap
39.40B
Enterprise Value
36.35B
1-Year Change
10.43%
Ranking
Category
Stock Price
$346.50
ChartMarket Cap Chart
Since February 3, 2016, BeOne Medicines AG's market cap has increased from $861.90M to $39.40B, an increase of 4,471.03%. That is a compound annual growth rate of 43.31%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2026 | 39.40B | 17.22% |
| Dec 31, 2025 | 33.61B | 70.71% |
| Dec 31, 2024 | 19.69B | 4.41% |
| Dec 29, 2023 | 18.86B | -17.40% |
| Dec 30, 2022 | 22.83B | -10.17% |
| Dec 31, 2021 | 25.41B | 8.12% |
| Dec 31, 2020 | 23.50B | 133.90% |
| Dec 31, 2019 | 10.05B | 20.62% |
| Dec 31, 2018 | 8.33B | 87.56% |
| Dec 29, 2017 | 4.44B | 342.97% |
| Dec 30, 2016 | 1.00B | 16.34% |
| Feb 3, 2016 | 861.90M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Regeneron Pharmaceuticals | 78.04B |
| argenx SE | 61.97B |
| Moderna | 57.48B |
| Revolution Medicines | 43.68B |
| Royalty Pharma | 33.70B |
| Alnylam Pharmaceuticals | 33.28B |
| Roivant Sciences | 29.49B |
| Insmed | 28.26B |